WO2001018046A3 - Ovarian tumor sequences and methods of use therefor - Google Patents

Ovarian tumor sequences and methods of use therefor Download PDF

Info

Publication number
WO2001018046A3
WO2001018046A3 PCT/US2000/024827 US0024827W WO0118046A3 WO 2001018046 A3 WO2001018046 A3 WO 2001018046A3 US 0024827 W US0024827 W US 0024827W WO 0118046 A3 WO0118046 A3 WO 0118046A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
ovarian tumor
use therefor
compositions
tumor sequences
Prior art date
Application number
PCT/US2000/024827
Other languages
French (fr)
Other versions
WO2001018046A2 (en
Inventor
Jiangchun Xu
John A Stolk
Original Assignee
Corixa Corp
Jiangchun Xu
John A Stolk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/640,173 external-priority patent/US6613515B1/en
Application filed by Corixa Corp, Jiangchun Xu, John A Stolk filed Critical Corixa Corp
Priority to CA002384499A priority Critical patent/CA2384499A1/en
Priority to EP00960080A priority patent/EP1212354A2/en
Priority to AU71297/00A priority patent/AU7129700A/en
Publication of WO2001018046A2 publication Critical patent/WO2001018046A2/en
Publication of WO2001018046A3 publication Critical patent/WO2001018046A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Compositions and methods for the therapy and diagnosis of cancer, such as ovarian cancer, are disclosed. Compositions may comprise one or more ovarian carcinoma proteins, portions thereof, polynucleotides that encode such portions or antibodies or immune system cells specific for such proteins. Such compositions may be used, for example, for the prevention and treatment of diseases such as ovarian cancer. Polypeptides and polynucleotides as provided herein may further be used for the detection and monitoring of ovarian cancer.
PCT/US2000/024827 1999-09-10 2000-09-08 Ovarian tumor sequences and methods of use therefor WO2001018046A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002384499A CA2384499A1 (en) 1999-09-10 2000-09-08 Ovarian tumor sequences and methods of use therefor
EP00960080A EP1212354A2 (en) 1999-09-10 2000-09-08 Ovarian tumor sequences and methods of use therefor
AU71297/00A AU7129700A (en) 1999-09-10 2000-09-08 Ovarian tumor sequences and methods of use therefor

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US39437499A 1999-09-10 1999-09-10
US09/394,374 1999-09-10
US56177800A 2000-05-01 2000-05-01
US09/561,778 2000-05-01
US09/640,173 US6613515B1 (en) 1999-09-10 2000-08-15 Ovarian tumor sequences and methods of use therefor
US09/640,173 2000-08-15
US65666800A 2000-09-07 2000-09-07
US09/656,668 2000-09-07

Publications (2)

Publication Number Publication Date
WO2001018046A2 WO2001018046A2 (en) 2001-03-15
WO2001018046A3 true WO2001018046A3 (en) 2001-09-13

Family

ID=27503365

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/024827 WO2001018046A2 (en) 1999-09-10 2000-09-08 Ovarian tumor sequences and methods of use therefor

Country Status (4)

Country Link
EP (1) EP1212354A2 (en)
AU (1) AU7129700A (en)
CA (1) CA2384499A1 (en)
WO (1) WO2001018046A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100543857B1 (en) * 1999-09-01 2006-01-23 제넨테크, 인크. Promotion or Inhibition of Angiogenesis and Cardiovascularization
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
US20020072503A1 (en) * 2000-03-28 2002-06-13 Jiangchun Xu Compositions and methods for the therapy and diagnosis of ovarian cancer
US6632630B2 (en) 2000-03-29 2003-10-14 Aclara Biosciences, Inc. Monooxygenase assays
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7691567B2 (en) 2000-10-30 2010-04-06 Board Of Regents, The University Of Texas System Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin
US7157558B2 (en) 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
US20050272120A1 (en) 2001-06-20 2005-12-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP2000482A1 (en) * 2001-06-20 2008-12-10 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
AU2002359777A1 (en) * 2001-12-21 2003-07-30 Idec Pharmaceuticals Corporation Genes overexpresses by ovarian cancer and their use in developing novel therapeutics especially antibodies
AU2003230874A1 (en) * 2002-04-16 2003-11-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US9200036B2 (en) 2002-07-12 2015-12-01 The Johns Hopkins University Mesothelin vaccines and model systems
US20090110702A1 (en) 2002-07-12 2009-04-30 The Johns Hopkins University Mesothelin Vaccines and Model Systems and Control of Tumors
EP1575500A4 (en) 2002-07-12 2007-01-03 Univ Johns Hopkins Mesothelin vaccines and model systems
US20090016963A1 (en) * 2003-10-22 2009-01-15 Dalia Cohen Genes involved in neurodegenerative conditions
AR059900A1 (en) 2006-03-17 2008-05-07 Genentech Inc ANTI-TAT226 ANTIBODIES AND IMMUNOCATE PLAYERS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037418A2 (en) * 1997-02-25 1998-08-27 Corixa Corporation Compounds for immunodiagnosis of prostate cancer and methods for their use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037418A2 (en) * 1997-02-25 1998-08-27 Corixa Corporation Compounds for immunodiagnosis of prostate cancer and methods for their use

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 10 March 2000 (2000-03-10), FLECKENSTEIN B. P. AND ENSSER, A. D.: "Human and murine semaphorin L", XP002153262 *
DATABASE EMBL 14 December 1999 (1999-12-14), MUZNEY, D. M. ET AL.: "Homo sapiens clone RP11-50I19", XP002153261 *
DATABASE EMBL 31 July 1997 (1997-07-31), MARRA, M. ET AL.: "The WashU-HHMI mouse EST project", XP002153260 *
DATABASE EMBL 6 May 1998 (1998-05-06), PIRTSKHALAISHVILI, G. ET AL.: "Transduction of dendritic cells ...", XP002153258 *
DATABASE EMBL 7 May 1999 (1999-05-07), ENSSER A. AND FLECKENSTEIN B.: "Semaphorin L.", XP002153259 *
MEDEN H ET AL: "Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor.", EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY, (1997 FEB) 71 (2) 173-9. REF: 36, XP000943740 *

Also Published As

Publication number Publication date
AU7129700A (en) 2001-04-10
EP1212354A2 (en) 2002-06-12
CA2384499A1 (en) 2001-03-15
WO2001018046A2 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
WO2002006317A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2000036107A3 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
WO1997025426A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO2002060317A3 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
WO2002074156A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2001040269A3 (en) Compositions and methods for therapy and diagnosis of breast cancer
WO2001025272A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
WO2002089747A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2002092001A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2002074237A8 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
WO2000037643A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO1998045328A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
WO2002012328A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2002078516A3 (en) Compositions and methods for the therapy and diagnosis of cancer
WO2003037267A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2002058534A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2001049716A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO2003013431A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2002012280A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2001090152A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2000078960A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO1999037775A3 (en) Compositions and methods for detecting and treating breast cancer
WO2001070976A3 (en) Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2384499

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000960080

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000960080

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000960080

Country of ref document: EP